Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/andr.13097 http://scihub22266oqcxt.onion/10.1111/andr.13097 34409772!8444879!34409772     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Andrology 2022 ; 10 (1): 34-41 Nephropedia Template TP {{tp|p=34409772|t=2022. Testosterone in males with COVID-19: A 7-month cohort study |pdf=|usr=}}{{34409772}} gab.com Text Testosterone in males with COVID-19: A 7-month cohort study JO: Andrology http://www.kidney.de/pget.php?&tw=1&pmid=34409772 #FOAvip BACKGROUND: Circulating testosterone levels have been found to be reduced in men with severe acute respiratory syndrome coronavirus 2 infection, COVID-19, with lower levels being associated with more severe clinical outcomes. OBJECTIVES: We aimed to assess total testosterone levels and the prevalence of total testosterone still suggesting for hypogonadism at 7-month follow-up in a cohort of 121 men who recovered from laboratory-confirmed COVID-19. MATERIALS AND METHODS: Demographic, clinical, and hormonal values were collected for all patients. Hypogonadism was defined as total testosterone </=9.2 nmol/L. The Charlson Comorbidity Index was used to score health-significant comorbidities. Descriptive statistics and multivariable linear and logistic regression models tested the association between clinical and laboratory variables and total testosterone levels at follow-up assessment. RESULTS: Circulating total testosterone levels increased at 7-month follow-up compared to hospital admittance (p < 0.0001), while luteinizing hormone and 17beta-estradiol levels significantly decreased (all p </= 0.02). Overall, total testosterone levels increased in 106 (87.6%) patients, but further decreased in 12 (9.9%) patients at follow-up, where a total testosterone level suggestive for hypogonadism was still observed in 66 (55%) patients. Baseline Charlson Comorbidity Index score (OR 0.36; p = 0.03 [0.14, 0.89]) was independently associated with total testosterone levels at 7-month follow-up, after adjusting for age, BMI, and IL-6 at hospital admittance. CONCLUSIONS: Although total testosterone levels increased over time after COVID-19, more than 50% of men who recovered from the disease still had circulating testosterone levels suggestive for a condition of hypogonadism at 7-month follow-up. In as many as 10% of cases, testosterone levels even further decreased. Of clinical relevance, the higher the burden of comorbid conditions at presentation, the lower the probability of testosterone levels recovery over time. Twit Text FOAVip Testosterone in males with COVID-19: A 7-month cohort study ????Andrology http://www.kidney.de/pget.php?&tw=1&pmid=34409772 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34409772 #FOAvip English Wikipedia <ref>{{Cite pmid|34409772}}</ref> Testosterone in males with COVID-19: A 7-month cohort study #MMPMID34409772 Salonia A; Pontillo M; Capogrosso P; Gregori S; Carenzi C; Ferrara AM; Rowe I; Boeri L; Larcher A; Ramirez GA; Tresoldi C; Locatelli M; Cavalli G; Dagna L; Castagna A; Zangrillo A; Tresoldi M; Landoni G; Rovere-Querini P; Ciceri F; Montorsi F Andrology 2022[Jan]; 10 (1): 34-41 PMID34409772show ga BACKGROUND: Circulating testosterone levels have been found to be reduced in men with severe acute respiratory syndrome coronavirus 2 infection, COVID-19, with lower levels being associated with more severe clinical outcomes. OBJECTIVES: We aimed to assess total testosterone levels and the prevalence of total testosterone still suggesting for hypogonadism at 7-month follow-up in a cohort of 121 men who recovered from laboratory-confirmed COVID-19. MATERIALS AND METHODS: Demographic, clinical, and hormonal values were collected for all patients. Hypogonadism was defined as total testosterone |Aged[MESH] |COVID-19/*blood[MESH] |Cohort Studies[MESH] |Humans[MESH] |Hypogonadism/epidemiology/virology[MESH] |Male[MESH] |Middle Aged[MESH] |Prevalence[MESH] |SARS-CoV-2[MESH]Testosterone in males with COVID-19: A 7-month cohort study (epmc).pdf DeepDyve Pubget Overpricing